SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (6803)4/10/1998 10:24:00 PM
From: av ram  Read Replies (2) of 23519
 
<<Let Pfe spend the big $$$ on binging the paients into the Dr's offices.>>

I think VVUS is planning to win more Dr. by spending more as indicated in this news. (I hope they do it wisely as they can't afford to spend as much as PFE)

Reuters, Thursday, April 09, 1998 at 08:32

MOUNTAIN VIEW, Calif., April 9 (Reuters) - Vivus Inc. said
Thursday it plans to spend "aggressively" on sales and
marketing of its impotence treatment products during the rest
of the year.
Vivus reported a net loss of $2.4 million or $0.07 per
share, for the first quarter, compared with net income of $9.6
million, $0.27 per share, for the same period in 1997, the
company said in a statement.
Product revenues for the first quarter were $26.5 million
compared with $27.8 million for the same period in 1997 and
$29.0 million for the fourth quarter of 1997.
The company said increased sales and marketing spending
will be directed at doctors through Vivus' sales force, rather

than through direct consumer advertising.

Copyright 1998, Reuters News Service
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext